New Body Line Sees Significant Improvement in Operational Performance
After a disappointing 2024, New Body Line has shown a marked improvement in its operational performance in the first half of 2025. Revenue has jumped by 52.9% year-over-year, indicating a significant recovery in activity. Thanks to this momentum, operating profit has risen to 0.436 MTND, an increase of 19.6% compared to the same period in 2024.
Net Result Impacted by Provisions
In contrast, the net result has slightly declined, reaching 0.580 MTND, compared to 0.594 MTND a year earlier. This decrease is mainly due to the impact of provisions related to investments with the Tunisian-Saudi Investment Brokerage Company (TSI). The company has indeed strengthened its provisions in the first half of 2025 by 0.200 MTND to cover all its treasury bill investments and has set up a new provision of 0.306 MTND to cover the liquidity still held in an account opened with TSI. In total, the provision effort amounted to 0.506 MTND for the period, affecting the net profit.
Positive Outlook Despite Non-Recurring Items
Despite these non-recurring items, the outlook remains positive. New Body Line is on track to regain its historical levels of profitability this year. A dividend distribution is still possible if the trend is confirmed in the second half.
Stock Performance
On the stock market, the share price has been penalized by investor caution, recording an 11.1% decline since the beginning of the year. The company will now have to regain market confidence to reverse the trend.
